Cyclosporine A in children with ABCA3 deficiency
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.27178 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Xiaohua Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dr. von Haunersches Kinderspital, University of Munich, German Center for Lung Research (DZL), Munich, Germany. Hauptthemen laut MEDLINE: ATP-Binding Cassette Transporters, Cyclosporine, Hydroxychloroquine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinsachft (DFG Gr 970/9-2), UK child lung foundation, German center for Lung Research, CPC Munich (82DZL053B2).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Biallelic ATP‐binding cassette subfamily A member 3 (ABCA3) variants can cause interstitial lung disease in children and adults, for which no proven treatments exist. Recent in vitro evidence suggested that cyclosporine A (CsA) could correct some ABCA3 variants, however for other variants this is unknown and no data in patients exist.
Methods
We retrieved the clinical data of two children aged 2 and 4 years carrying homozygous ABCA3 variants (G210C and Q1045R, respectively) and empiric CsA treatment from the Kids Lung Register database. In vitro experiments functionally characterized the two variants and explored the effects of CsA alone or combined with hydroxychloroquine (HCQ) in a human alveolar epithelial cell line (A549) derived from adenocarcinoma cells.
Results
Six weeks following the introduction of CsA, both children required a reduced O 2 flow supply, which then remained stable on CsA. Later, when CsA was discontinued, the clinical status of the children remained unchanged. Of note, the children simultaneously received prednisolone, azithromycin, and HCQ. In vitro, both ABCA3 variants demonstrated defective lysosomal colocalization and impaired ABCA3 + vesicle size, with proteolytic cleavage impairment only in Q1045R. CsA alone corrected the trafficking impairment and ABCA3 + vesicle size of both variants with a variant‐specific effect on phosphatidylcholine recycling in G210C. CsA combined with HCQ were additive for improving trafficking of ABCA3 in G210C, but not in Q1045R.
Conclusions
CsA treatment might be helpful for certain patients with ABCA3 deficiency, however, currently strong clinical supporting evidence is lacking. Appropriate trials are necessary to overcome this unmet need.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. von Haunersches Kinderspital, University of Munich, German Center for Lung Research (DZL), Munich, Germany.
- Research Unit Signaling and Translation, Helmholtz Zentrum München, Neuherberg, Germany.
- Pediatric Pneumology and Allergology, University Children's Inselspital Bern, University of Bern, Bern, Switzerland.
- Department of Pediatric Pulmonology, Faculty of Medicine, Gazi University, Ankara, Turkey.
ORCID-Profile: Xiaohua Yang, Tugba E Şismanlar, Matthias Griese
Förderung
- Deutsche Forschungsgemeinsachft (DFG Gr 970/9-2)
- UK child lung foundation
- German center for Lung Research, CPC Munich (82DZL053B2)
Zitieren
APA
Yang, X., Forstner, M. E., Rothenaigner, I., Bullo, M., Şismanlar, T. E., Aslan, A. T., Latzin, P., Hadian, K., & Griese, M. (2024). Cyclosporine A in children with ABCA3 deficiency. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27178
Vancouver
Yang X, Forstner ME, Rothenaigner I, Bullo M, Şismanlar TE, Aslan AT, et al. Cyclosporine A in children with ABCA3 deficiency. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27178
BibTeX
@article{Yang2024,
author = {Yang, Xiaohua and Forstner, Maria E and Rothenaigner, Ina and Bullo, Marina and Şismanlar, Tugba E and Aslan, Ayse T and Latzin, Philipp and Hadian, Kamyar and Griese, Matthias},
title = {Cyclosporine A in children with ABCA3 deficiency},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.27178}
}
EUVIMED